David McArthur
Corporate Officer/Principal bij 3 SIXTY RISK SOLUTIONS LTD.
Profiel
David McArthur is currently a Director at African Cannabis Corp., Chief of Staff at Canada Department of Natural Resources, and Chief Corporate Affairs Officer at 3 Sixty Risk Solutions Ltd.
He previously worked as Chief of Staff at Indigenous & Northern Affairs Canada and Department of Canadian Heritage.
Actieve functies van David McArthur
Bedrijven | Functie | Begin |
---|---|---|
3 SIXTY RISK SOLUTIONS LTD. | Corporate Officer/Principal | - |
Canada Department of Natural Resources | Human Resources Officer | - |
African Cannabis Corp.
African Cannabis Corp. Medical/Nursing ServicesHealth Services African Cannabis Corp. engages in providing cannabis products. It offers dried cannabis flower and cannabis oil products for medical uses. The firm's cannabis are used for the treatment of anxiety/stress disorders, metabolic disorders/diabetes, neuro inflammation, neurological disorders/epilepsy, oxidative injury, nausea and schizophrenia. The company was founded by Kojo Annan and Carl Esprey in 2018 and is headquartered in Toronto, Canada. | Directeur/Bestuurslid | - |
Eerdere bekende functies van David McArthur
Bedrijven | Functie | Einde |
---|---|---|
Indigenous & Northern Affairs Canada | Human Resources Officer | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
3 SIXTY RISK SOLUTIONS LTD. | Finance |
Bedrijven in privébezit | 3 |
---|---|
Canada Department of Natural Resources | Government |
Indigenous & Northern Affairs Canada | |
African Cannabis Corp.
African Cannabis Corp. Medical/Nursing ServicesHealth Services African Cannabis Corp. engages in providing cannabis products. It offers dried cannabis flower and cannabis oil products for medical uses. The firm's cannabis are used for the treatment of anxiety/stress disorders, metabolic disorders/diabetes, neuro inflammation, neurological disorders/epilepsy, oxidative injury, nausea and schizophrenia. The company was founded by Kojo Annan and Carl Esprey in 2018 and is headquartered in Toronto, Canada. | Health Services |